145-PATIENT EXPERIENCE OF NEVA IN FIRST-LINE USE
Paper:
First pass results of mechanical thrombectomy with two-drop zone NeVa™ deviceAuthors:
Arsida Bajrami1, Ozgur Ertugrul2, Songul Senadim1, Eren Erdem2, Feyyaz Baltacioglu3 and Serdar Geyik2Journal:
Interventional Neuroradiology – OCTOBER 2022Background:
Occlusive thrombi in acute ischemic stroke can be in various types which limits the success of the thrombectomy. The NeVa™ (Vesalio, Nashville, Tennessee) thrombectomy device was originally designed for all types of clot. Our aim was to evaluate the efficacy and safety of the NeVaTM device for mechanical thrombectomy.Results:
There was female pre-dominance (54.5%).
Median presenting national institutes of health stroke scale (NIHSS) was 16 (IQR, 3–32).
88 MCA-m1 (60,6%), 43 ICA-tip (29,6%), 11 MCA-m2 (7,5%), 2 ACA (1,4%) and 1 basilar (0,7%) occlusions underwent mechanical thrombectomy.
Median procedure time was 25 min (IQR, 7–136).
First-pass reperfusion scores were:
➔ mTICI 0–2a 22.7%,
➔ mTICI 2b 23.4%,
➔ mTICI 2c 17.9%
➔ mTICI 3 35.9%
Final reperfusion scores were:
➔ mTICI 2b-3 97.9%
➔ mTICI 2c-3 87.6%
Mean number of passes to achieve final recanalization was 1,84±1,14.
No device related adverse event occurred.
The mean 24-h NIHSS score was 6 (IQR 0–33).